about
sameAs
Nosocomial infections in very low birthweight infants in Germany: current data from the National Surveillance System NEO-KISS.Regional distribution of nosocomial infections due to ESBL-positive Enterobacteriaceae in Germany: data from the German National Reference Center for the Surveillance of Nosocomial Infections (KISS).Risk factors associated with the community-acquired colonization of extended-spectrum beta-lactamase (ESBL) positive Escherichia Coli. an exploratory case-control study.Attributable costs of ventilator-associated lower respiratory tract infection (LRTI) acquired on intensive care units: a retrospectively matched cohort studySepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K. pneumoniae and E. coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype.Nosocomial infection and antibiotic use: a second national prevalence study in GermanyE. coli bacteremia in comparison to K. pneumoniae bacteremia: influence of pathogen species and ESBL production on 7-day mortality.Prolonged outbreak of clonal MDR Pseudomonas aeruginosa on an intensive care unit: contaminated sinks and contamination of ultra-filtrate bags as possible route of transmission?Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection.Antibiotic stewardship in Germany: a cross-sectional questionnaire survey of 355 intensive care units.Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany.Molecular epidemiology of extended-spectrum beta-lactamase (ESBL)-positive Klebsiella pneumoniae from bloodstream infections and risk factors for mortality.Scabies outbreak among healthcare workers in a German acute care hospital.The mother as most important risk factor for colonization of very low birth weight (VLBW) infants with extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E).Antibiotic usage in German hospitals: results of the second national prevalence study.Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort.Emergence of extended-spectrum β-lactamase (ESBL) CTX-M-8 in Germany.Pyoderma outbreak among kindergarten families: Association with a Panton-Valentine leukocidin (PVL)-producing S. aureus strain.Scabies, Periorbital Cellulitis and Recurrent Skin Abscesses due to Panton-Valentine Leukocidin-Positive Staphylococcus aureus Mimic Hyper IgE Syndrome in an Infant.Panton-Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy.Costs and length of stay associated with extended-spectrum β-lactamase production in cases of Escherichia coli bloodstream infection.The association of ESBL-producing Enterobacteriaceae (ESBL-E) carriage in humans with pigs.Prevalence of MRSA and Gram-negative bacteria with ESBLs and carbapenemases in patients from Northern Africa at a German hospital.Periorbital infections and conjunctivitis due to Panton-Valentine Leukocidin (PVL) positive Staphylococcus aureus in childrenAdmission prevalence of colonization with third-generation cephalosporin-resistant Enterobacteriaceae and subsequent infection rates in a German university hospitalPredictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonizationCosts and prolonged length of stay of central venous catheter-associated bloodstream infections (CVC BSI): a matched prospective cohort studyThe importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infectionsExtended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli Isolated from Flies in the Urban Center of Berlin, Germany.Staphylococcus Aureus Bacteriuria as a Predictor of In-Hospital Mortality in Patients with Staphylococcus Aureus Bacteremia. Results of a Retrospective Cohort StudySevere infections of Panton-Valentine leukocidin positive Staphylococcus aureus in childrenInfections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniaeOutpatient decolonization after recurrent skin infection with Panton-Valentine leukocidin (PVL)-producing S. aureus-The importance of treatment repetitionLean back and wait for the alarm? Testing an automated alarm system for nosocomial outbreaks to provide support for infection control professionals
P50
Q30606615-AACB1EE3-93E6-4032-83CA-D12AF01AF955Q30888793-5B313471-07CF-4ABF-B9A4-49695545F8E5Q34989958-1B4DC848-1428-4870-A7A2-EB9A145F4C22Q36751642-FC61ABD8-F9E0-4F09-8EE3-13B0DD0FC2B6Q37114901-6FDE4260-2D5D-46BA-A3A2-84F5D5A81670Q37229251-50C1E7B3-F4BD-4F15-A391-7E4382CD79BFQ37350084-190C97D7-FD6B-449C-A5F1-1B868BF0B36FQ37476337-679FB2C6-03C3-4321-921D-3E5E0566B316Q37644572-A9388664-8371-4448-BC22-F7AB19F8F876Q39330678-9FEE2F86-9A06-430D-BB90-9A2EA8872A24Q40876635-3875B3B7-E595-4A82-9D25-6080426B9C61Q41738073-DA20B15D-8953-4A56-9F75-BE8C6AF725C3Q41921830-F0892E37-F956-4CC9-8F0C-C48246AF5D92Q42219507-2A6DFDEE-35C5-454D-9657-06D7A9E476C5Q44610203-020660DF-36AA-432C-9E20-36660F735D4EQ45381829-3CA5EB68-E226-4681-AD6F-57BB12B16B03Q45765789-9692A8EF-B822-48ED-A318-36E699CA909CQ47098119-5416C1C0-4A63-43C5-AE91-E0996C1A6917Q47761412-860CDDE4-C60A-4D0E-B597-4CAA1C76E235Q48549522-4CD4AD3D-9203-4603-B91A-2AE4C96FE31BQ50676034-92A106A4-68F4-4324-85C8-EC68725D3136Q52861643-A1B7FC39-0095-4F7E-8DEC-D21637D32902Q52863845-186C1BB1-DBC7-4EAA-8FE8-151E15BBE129Q56746226-B4486568-5357-4139-933A-9DA722A564BCQ56751432-641FD2A3-A788-4408-B471-4294E7F3DA06Q56958046-ABEE3507-4663-411B-8F67-1387CD64F70FQ56961270-7737DD2C-A58A-473C-A68E-31E2F9E3310DQ59136153-2A8C54A0-2D5F-4036-ADDB-2F98444C3BBEQ64956724-F2ECBCF7-2401-43BD-8A1E-542E03498252Q89761350-0A6A6E09-FA86-402D-B90E-FC082296417FQ90372157-F1EDFA98-AAEA-481D-8095-5DC7AA2F3885Q91758700-14929C7D-7494-4569-97BE-C24CD986CC4EQ92115460-1EBE6EE1-8FC1-43D1-A938-3BC679B6A989Q92914723-10E807CF-1522-423A-887B-5235F9F931CA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rasmus Leistner
@ast
Rasmus Leistner
@en
Rasmus Leistner
@es
Rasmus Leistner
@nl
type
label
Rasmus Leistner
@ast
Rasmus Leistner
@en
Rasmus Leistner
@es
Rasmus Leistner
@nl
prefLabel
Rasmus Leistner
@ast
Rasmus Leistner
@en
Rasmus Leistner
@es
Rasmus Leistner
@nl
P106
P108
P31
P496
0000-0002-1225-9023